A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult Participants

NCT06181006 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Pirtobrutinib

Sponsor

Eli Lilly and Company

Collaborators

[object Object]